Statistics
Total Visits
Views | |
---|---|
CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: Results of the HE22A99 trial of the hellenic cooperative oncology group | 168 |
Total Visits Per Month
March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
---|---|---|---|---|---|---|---|
CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: Results of the HE22A99 trial of the hellenic cooperative oncology group | 3 | 0 | 4 | 10 | 6 | 4 | 2 |
Top country views
Views | |
---|---|
United States | 73 |
Poland | 52 |
China | 17 |
France | 4 |
Sweden | 4 |
Australia | 3 |
Canada | 2 |
Germany | 2 |
Ireland | 2 |
Argentina | 1 |
Top cities views
Views | |
---|---|
Warsaw | 52 |
Louisville | 9 |
Boardman | 8 |
Des Moines | 7 |
San Ramon | 7 |
Falls Church | 6 |
Ann Arbor | 5 |
San Diego | 5 |
Ashburn | 4 |
Beijing | 4 |